Interaction Mechanisms of KRAS G12C Inhibitors (Sotorasib and Adagrasib) with Human Serum Albumin: Insights from Spectroscopic and Molecular Docking Studies
Molecules · 2025
DOI: 10.3390/molecules30163436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Junsong Qin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center of Tropical Medicine Innovation and Transformation of Ministry of Education, Hainan Provincial Key Laboratory of Research…. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Serum Albumin, Human, Proto-Oncogene Proteins p21(ras), Pyrimidines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China (81560042), start-up research grant, Hainan Medical University undergraduate innovative experimental project.
Abstract (Originalsprache)
This study systematically explored the interaction mechanisms between two KRAS G12C inhibitors (Sotorasib and Adagrasib) and human serum albumin (HSA) via UV-vis spectroscopy, fluorescence spectroscopy, three-dimensional fluorescence spectroscopy, and molecular docking methods. The experimental findings demonstrated that both drugs caused static quenching of HSA fluorescence, with binding constants of 13.64 × 103 M−1 (Sotorasib) and 63.67 × 103 M−1 (Adagrasib), demonstrating significant selectivity differences in their binding affinities. UV spectral analysis demonstrated distinct microenvironmental perturbations: Sotorasib and Adagrasib induced a shift (∆λ = 7 nm and ∆λ = 8 nm, respectively) at 211 nm, consistent with altered polarity in HSA’s binding pockets. Fluorescence spectroscopy confirmed a 1:1 binding stoichiometry, with Stern-Volmer analysis validating static quenching as the dominant mechanism. Three-dimensional fluorescence spectra further highlighted Adagrasib’s stronger conformational impact, reducing tyrosine and tryptophan residue fluorescence intensities by 16% (Peak 1) and 10% (Peak 2), respectively, compared to Sotorasib. Molecular docking revealed divergent binding modes: Sotorasib occupied Sudlow Site I via three hydrogen bonds and hydrophobic interactions (∆G = −24.60 kJ·mol−1), whereas Adagrasib bound through one hydrogen bond and hydrophobic forces (∆G = −30.92 kJ·mol−1), with stability differences attributed to structural characteristics. This study uses multispectral technology and molecular docking to reveal the binding mechanism of Sotorasib and Adagrasib with HSA, providing a theoretical basis for designing highly targeted albumin nanocarriers. The strong binding properties of Adagrasib and HSA may reduce the toxicity of free drugs, providing direction for the development of long-acting formulations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Engineering Research Center of Tropical Medicine Innovation and Transformation of Ministry of Education, Hainan Provincial Key Laboratory of Research and Development on Tropical Herbs, School of Pharmacy, Hainan Medical…
- Key Laboratory of Tropical Translational Medicine of Ministry of Education, Key Laboratory of Brain Science Research Transformation in Tropical Environment of Hainan Province, School of Basic Medicine and Life Sciences,…
Förderung
- National Natural Science Foundation of China (81560042)
- start-up research grant
- Hainan Medical University undergraduate innovative experimental project
Zitieren
APA
Qin, J., Chen, Z., Wang, C., Mai, L., Wang, X., Li, J., Liu, H., & Song, Y. (2025). Interaction Mechanisms of KRAS G12C Inhibitors (Sotorasib and Adagrasib) with Human Serum Albumin: Insights from Spectroscopic and Molecular Docking Studies. Molecules. https://doi.org/10.3390/molecules30163436
Vancouver
Qin J, Chen Z, Wang C, Mai L, Wang X, Li J, et al. Interaction Mechanisms of KRAS G12C Inhibitors (Sotorasib and Adagrasib) with Human Serum Albumin: Insights from Spectroscopic and Molecular Docking Studies. Molecules. 2025. doi:10.3390/molecules30163436
BibTeX
@article{Qin2025,
author = {Qin, Junsong and Chen, Zhepeng and Wang, Chuangyan and Mai, Lin and Wang, Xian and Li, Junfeng and Liu, Hui and Song, Yun},
title = {Interaction Mechanisms of KRAS G12C Inhibitors (Sotorasib and Adagrasib) with Human Serum Albumin: Insights from Spectroscopic and Molecular Docking Studies},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30163436}
}
EUVIMED